(19)
(11) EP 4 739 311 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24835499.5

(22) Date of filing: 03.07.2024
(51) International Patent Classification (IPC): 
A61K 31/437(2006.01)
 A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/437; A61P 35/00; A61K 31/519; A61K 31/4523; A61K 31/4184; A61K 31/497; A61K 31/506
 
C-Sets:
  1. A61K 31/437, A61K 2300/00;
  2. A61K 31/506, A61K 2300/00;
  3. A61K 31/519, A61K 2300/00;
  4. A61K 31/4523, A61K 2300/00;
  5. A61K 31/4184, A61K 2300/00;
  6. A61K 31/497, A61K 2300/00;
(86) International application number:
PCT/HU2024/050051
(87) International publication number:
WO 2025/008650 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 03.07.2023 HU 2300231
22.02.2024 HU 2400147

(71) Applicant: Országos Onkológiai Intézet
1122 Budapest (HU)

(72) Inventors:
  • NAGY, Péter
    2000 Szentendre (HU)
  • ERDÉLYI, Katalin
    2040 Budaörs (HU)
  • BORBÉNYI-GALAMBOS, Klaudia
    9182 Károlyháza (HU)

(74) Representative: Danubia Patent & Law Office LLC 
Bajcsy-Zsilinszky út 16
1051 Budapest
1051 Budapest (HU)

   


(54) CSE INHIBITOR FOR USE IN THE TREATMENT OF A TUMOR IN COMBINATION WITH A MAPK INHIBITOR